SBIO Holdings Information

SBIO is an equity ETF with a total of 95 individual holdings. The top holdings are Kymera Therapeutics stock at 4.08%, Celcuity at 2.95%, ACADIA Pharmaceuticals at 2.93%, Alkermes at 2.93%, and Crinetics Pharmaceuticals at 2.87%.

Total Holdings

Top 10 Percentage

28.96%

Asset Class

Equity

ETF Category

Health

Assets

126.84M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	KYMR	Kymera Therapeutics, Inc.	4.08%	63,427
2	CELC	Celcuity Inc.	2.95%	37,134
3	ACAD	ACADIA Pharmaceuticals Inc.	2.93%	135,943
4	ALKS	Alkermes plc	2.93%	132,671
5	CRNX	Crinetics Pharmaceuticals, Inc.	2.87%	76,209
6	FOLD	Amicus Therapeutics, Inc.	2.73%	247,774
7	APGE	Apogee Therapeutics, Inc.	2.66%	44,022
8	GPCR	Structure Therapeutics Inc.	2.63%	48,730
9	VKTX	Viking Therapeutics, Inc.	2.62%	90,762
10	MIRM	Mirum Pharmaceuticals, Inc.	2.58%	41,253
11	NAMS	NewAmsterdam Pharma Company N.V.	2.51%	91,042
12	TVTX	Travere Therapeutics, Inc.	2.24%	71,795
13	VERA	Vera Therapeutics, Inc.	2.21%	51,344
14	TARS	Tarsus Pharmaceuticals, Inc.	2.17%	34,059
15	XENE	Xenon Pharmaceuticals Inc.	2.16%	62,034
16	NUVB	Nuvation Bio Inc.	2.03%	275,276
17	CGON	CG Oncology, Inc.	2.01%	64,714
18	APLS	Apellis Pharmaceuticals, Inc.	1.98%	101,620
19	IDYA	IDEAYA Biosciences, Inc.	1.94%	70,351
20	IRON	Disc Medicine, Inc.	1.89%	30,382
21	MLYS	Mineralys Therapeutics, Inc.	1.84%	63,689
22	EWTX	Edgewise Therapeutics, Inc.	1.80%	85,193
23	SYRE	Spyre Therapeutics, Inc.	1.60%	62,436
24	DNLI	Denali Therapeutics Inc.	1.55%	118,306
25	SRPT	Sarepta Therapeutics, Inc.	1.46%	84,319

Showing 25 of 95 holdings

Subscribe to see the full list

Activate Now

As of Dec 24, 2025